Published in Tidsskr Nor Laegeforen on April 20, 1999
[University duties at Sentralsykehuset in Akershus]. Tidsskr Nor Laegeforen (1999) 2.03
Deficits in psychologic and classroom performance of children with elevated dentine lead levels. N Engl J Med (1979) 9.80
The role of small nuclear ribonucleoprotein particles in pre-mRNA splicing. Nature (1987) 8.28
A role for exon sequences and splice-site proximity in splice-site selection. Cell (1986) 6.41
The protein Aly links pre-messenger-RNA splicing to nuclear export in metazoans. Nature (2000) 5.57
Intron sequences involved in lariat formation during pre-mRNA splicing. Cell (1985) 5.30
Splicing is required for rapid and efficient mRNA export in metazoans. Proc Natl Acad Sci U S A (1999) 4.26
SR proteins promote the first specific recognition of Pre-mRNA and are present together with the U1 small nuclear ribonucleoprotein particle in a general splicing enhancer complex. Mol Cell Biol (1994) 4.25
Natural evolution of late whiplash syndrome outside the medicolegal context. Lancet (1996) 4.13
An ATP-independent complex commits pre-mRNA to the mammalian spliceosome assembly pathway. Genes Dev (1991) 3.99
Pre-mRNA splicing and mRNA export linked by direct interactions between UAP56 and Aly. Nature (2001) 3.94
The splicing factor BBP interacts specifically with the pre-mRNA branchpoint sequence UACUAAC. Cell (1997) 3.68
Limitation of medical care: an ethnographic analysis. J Clin Ethics (1993) 3.45
Pain after whiplash: a prospective controlled inception cohort study. J Neurol Neurosurg Psychiatry (1999) 3.32
Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. J Clin Oncol (1992) 3.17
A novel set of spliceosome-associated proteins and the essential splicing factor PSF bind stably to pre-mRNA prior to catalytic step II of the splicing reaction. EMBO J (1994) 3.17
Protein components specifically associated with prespliceosome and spliceosome complexes. Genes Dev (1992) 3.16
Evidence that sequence-independent binding of highly conserved U2 snRNP proteins upstream of the branch site is required for assembly of spliceosomal complex A. Genes Dev (1996) 3.06
Evaluation of the effect of WIC supplemental feeding on birth weight. J Am Diet Assoc (1982) 2.92
An iron-regulated ferric reductase associated with the absorption of dietary iron. Science (2001) 2.90
A functional association between the 5' and 3' splice site is established in the earliest prespliceosome complex (E) in mammals. Genes Dev (1993) 2.83
Differential binding of heterogeneous nuclear ribonucleoproteins to mRNA precursors prior to spliceosome assembly in vitro. Mol Cell Biol (1992) 2.66
A potential role for U2AF-SAP 155 interactions in recruiting U2 snRNP to the branch site. Mol Cell Biol (1998) 2.62
Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis. Genes Dev (1998) 2.30
Identification of proteins that interact with exon sequences, splice sites, and the branchpoint sequence during each stage of spliceosome assembly. Mol Cell Biol (1996) 2.29
Functional association of U2 snRNP with the ATP-independent spliceosomal complex E. Mol Cell (2000) 2.27
Resolution of the mammalian E complex and the ATP-dependent spliceosomal complexes on native agarose mini-gels. RNA (1999) 2.06
Delayed spontaneous pubertal growth spurt in girls with the Ullrich-Turner syndrome. Am J Med Genet (1991) 2.05
Direct interactions between pre-mRNA and six U2 small nuclear ribonucleoproteins during spliceosome assembly. Mol Cell Biol (1994) 2.03
Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia (2000) 2.02
Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group. J Clin Oncol (1992) 2.00
Identification of both shared and distinct proteins in the major and minor spliceosomes. Science (1999) 1.96
Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke (1992) 1.89
Evidence that U5 snRNP recognizes the 3' splice site for catalytic step II in mammals. EMBO J (1997) 1.85
A two-step mechanism for 5' and 3' splice-site pairing. Nature (1995) 1.85
Identification of a functional mammalian spliceosome containing unspliced pre-mRNA. Proc Natl Acad Sci U S A (1988) 1.85
An X-ray and electron microscope study of tropomyosin. Biochem J (1948) 1.85
Blood pressure and risk of headache: a prospective study of 22 685 adults in Norway. J Neurol Neurosurg Psychiatry (2002) 1.74
Characterization of a protein complex containing spliceosomal proteins SAPs 49, 130, 145, and 155. Mol Cell Biol (1999) 1.73
Correspondence between a mammalian spliceosome component and an essential yeast splicing factor. Science (1993) 1.71
Association of guide RNA binding protein gBP21 with active RNA editing complexes in Trypanosoma brucei. Mol Cell Biol (1998) 1.66
Prevalence of migraine and non-migrainous headache--head-HUNT, a large population-based study. Cephalalgia (2000) 1.65
WW domain-mediated interactions reveal a spliceosome-associated protein that binds a third class of proline-rich motif: the proline glycine and methionine-rich motif. Proc Natl Acad Sci U S A (1998) 1.64
An upstream AG determines whether a downstream AG is selected during catalytic step II of splicing. Mol Cell Biol (2001) 1.57
Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ (2001) 1.57
The prespliceosome components SAP 49 and SAP 145 interact in a complex implicated in tethering U2 snRNP to the branch site. Genes Dev (1994) 1.57
Depression and anxiety disorders associated with headache frequency. The Nord-Trøndelag Health Study. Eur J Neurol (2003) 1.57
Human homologs of yeast prp16 and prp17 reveal conservation of the mechanism for catalytic step II of pre-mRNA splicing. EMBO J (1998) 1.56
Cyclin E associates with components of the pre-mRNA splicing machinery in mammalian cells. Mol Cell Biol (1998) 1.52
Calcium oxalate microcrystalline-associated arthritis in end-stage renal disease. Ann Intern Med (1982) 1.48
[Physician's statement concerning whiplash injuries. Significance of supplementary information]. Tidsskr Nor Laegeforen (1993) 1.47
In situ and small invasive breast cancer register in Victoria, 1988 to 1992: tumour characteristics and patient management. ANZ J Surg (2001) 1.42
The RNA splicing factor hSlu7 is required for correct 3' splice-site choice. Nature (1999) 1.40
Deficient learning and memory in early and middle phases of multiple sclerosis. J Neurol Neurosurg Psychiatry (1984) 1.40
Observation of an antimatter hypernucleus. Science (2010) 1.38
[Mononucleosis and neurological manifestations]. Tidsskr Nor Laegeforen (1993) 1.38
Head-HUNT: validity and reliability of a headache questionnaire in a large population-based study in Norway. Cephalalgia (2000) 1.31
Human step II splicing factor hSlu7 functions in restructuring the spliceosome between the catalytic steps of splicing. Genes Dev (1999) 1.30
Transposon-specified site-specific recombination. Proc Natl Acad Sci U S A (1982) 1.28
Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G. Lancet (1974) 1.27
Nomenclature for ion channel subunits. Science (2001) 1.26
Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Cancer (1986) 1.25
Accumulation of a novel spliceosomal complex on pre-mRNAs containing branch site mutations. Mol Cell Biol (1995) 1.24
Specific protein-protein interactions between the essential mammalian spliceosome-associated proteins SAP 61 and SAP 114. Proc Natl Acad Sci U S A (1994) 1.16
Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. Arterioscler Thromb Vasc Biol (1998) 1.15
Extracranial nerves in the posterior part of the head. Anatomic variations and their possible clinical significance. Spine (Phila Pa 1976) (1998) 1.13
Variable binding of propranolol in human serum. Biochem Pharmacol (1979) 1.12
A Ran-independent pathway for export of spliced mRNA. Nat Cell Biol (2001) 1.10
The co-occurrence of headache and musculoskeletal symptoms amongst 51 050 adults in Norway. Eur J Neurol (2002) 1.09
Impotence and nerve entrapment in long distance amateur cyclists. Acta Neurol Scand (1997) 1.09
Literacy and performance on the Mini-Mental State Examination. J Am Geriatr Soc (1995) 1.08
Interactions in the fourth dimension. Biotechnology (N Y) (1992) 1.08
Low socio-economic status is associated with increased risk of frequent headache: a prospective study of 22718 adults in Norway. Cephalalgia (2002) 1.04
Binding of theophylline in human serum determined by ultrafiltration and equilibrium dialysis. Br J Clin Pharmacol (1983) 1.03
Association of U2 snRNP with the spliceosomal complex E. Nucleic Acids Res (1997) 1.01
A new mutation in IVS-1 of the human beta globin gene causing beta thalassemia due to abnormal splicing. Blood (1987) 1.00
Multiple systems organ failure: I. The basal state. J Trauma (1981) 0.99
Erythema gyratum repens. Am J Med Sci (2001) 0.99
Aging, abstinence, and medical risk factors in the prediction of neuropsychologic deficit among long-term alcoholics. Arch Gen Psychiatry (1984) 0.98
Members of a family of proteins (the RD family) detected by a U1 70K monoclonal antibody are present in spliceosomal complexes. Nucleic Acids Res (1995) 0.98
Headache and transient focal neurological symptoms during pregnancy, a prospective cohort. Acta Neurol Scand (2005) 0.97
Idiopathic normal pressure hydrocephalus: the CSF tap-test may predict the clinical response to shunting. Acta Neurol Scand (1994) 0.97
Ethical and clinical issues with Native-American elders. End-of-life decision making. Clin Geriatr Med (1995) 0.97
Pharmacokinetic interactions with methotrexate: is 7-hydroxy-methotrexate the culprit? Lancet (1988) 0.97
The epidermal-dermal junction of normal human skin as seen in freeze-etch preparations. Br J Dermatol (1970) 0.97
Carcinoid-islet cell tumors of the duodenum. Ann Surg (1967) 0.96
Skeletal myogenesis: the preferred pathway of chick embryo epiblast cells in vitro. Dev Biol (1996) 0.96
Ethanol elimination rates in an ED population. Am J Emerg Med (1995) 0.96
Pregnancy following uterine fibroid embolization. Int J Gynaecol Obstet (2001) 0.95
Properties and biosynthesis of cyclopropane fatty acids in Escherichia coli. J Bacteriol (1979) 0.94
Impaired glucose tolerance in patients with chronic hypoxic pulmonary disease. Diabetes Metab (1996) 0.94
Immunoregulatory properties of antigenic fragments from bovine serum albumin. Cell Immunol (1983) 0.93
The frontotemporal peripheral nerves. Topographic variations of the supraorbital, supratrochlear and auriculotemporal nerves and their possible clinical significance. Surg Radiol Anat (2001) 0.93
Cognitive deficits, psychopathology, and psychosocial functioning in bipolar mood disorder. Neuropsychiatry Neuropsychol Behav Neurol (1998) 0.93
Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia (2008) 0.93
Exogenous ochronosis in the United States. J Am Acad Dermatol (1988) 0.92
Characterization of a cloned cDNA encoding rabbit myelin P2 protein. J Biol Chem (1988) 0.91
Receptor binding sites for beta-adrenergic ligands on human erythrocytes. Biochem Pharmacol (1982) 0.89
Subcutaneous hyphomycosis caused by Scytalidium hyalinum. Am J Clin Pathol (1984) 0.88
The diversity of seizures related to alcohol use. A study of consecutive patients. Eur J Neurol (1999) 0.88
Tension headache: botulinum toxin paralysis of temporal muscles. Headache (1994) 0.88